Abingdon Health Plc Cash Flow Conversion Efficiency
Abingdon Health Plc cash flow conversion efficiency. Based on the latest financial reports, Abingdon Health Plc (ABDX) has a cash flow conversion efficiency ratio of -0.204x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.28 Million ≈ $-156.10 USD) by net assets (GBX6.30 Million ≈ $766.65 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Abingdon Health Plc (2016–2025)
Cash flow conversion efficiency of Abingdon Health Plc from 2016 to 2025. This chart illustrates how Abingdon Health Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ABDX stock price for real-time trading data and today's change.
Abingdon Health Plc Cash Flow Conversion Ratio Explained
Abingdon Health Plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Abingdon Health Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abingdon Health Plc ranked by their cash flow conversion efficiency. Also see ABDX stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PCI Biotech Holding ASA
OL:PCIB
|
-0.501x |
|
Sino-German United AG
F:SGU
|
N/A |
|
Portmeirion Group PLC
LSE:PMP
|
-0.015x |
|
Kavango Resources PLC
LSE:KAV
|
-0.160x |
|
Virpax Pharmaceuticals Inc
NASDAQ:VRPX
|
3.142x |
|
CLARITY METALS CORP.
F:27G0
|
0.146x |
|
Sosandar Plc
LSE:SOS
|
0.053x |
|
HARVEST MINERALS LTD
F:7HM
|
N/A |
Annual Cash Flow Conversion Efficiency for Abingdon Health Plc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Abingdon Health Plc from 2016 to 2025. Review Abingdon Health Plc (ABDX) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | GBX5.30 Million ≈ $644.86 |
GBX-3.18 Million ≈ $-387.16 |
-0.600x | +18.61% |
| 2024-06-30 | GBX2.25 Million ≈ $273.64 |
GBX-1.66 Million ≈ $-201.85 |
-0.738x | -321.52% |
| 2023-06-30 | GBX3.01 Million ≈ $366.11 |
GBX1.00 Million ≈ $121.91 |
0.333x | +127.69% |
| 2022-06-30 | GBX6.43 Million ≈ $782.59 |
GBX-7.74 Million ≈ $-941.13 |
-1.203x | -99.19% |
| 2021-06-30 | GBX21.33 Million ≈ $2.59K |
GBX-12.88 Million ≈ $-1.57K |
-0.604x | -179.22% |
| 2020-06-30 | GBX2.75 Million ≈ $334.47 |
GBX2.10 Million ≈ $254.90 |
0.762x | +610.73% |
| 2019-06-30 | GBX6.09 Million ≈ $740.58 |
GBX-908.25K ≈ $-110.51 |
-0.149x | +65.99% |
| 2018-06-30 | GBX5.81 Million ≈ $707.29 |
GBX-2.55 Million ≈ $-310.29 |
-0.439x | -103.06% |
| 2016-12-31 | GBX-115.66K ≈ $-14.07 |
GBX-1.66 Million ≈ $-201.83 |
14.342x | -- |
About Abingdon Health Plc
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant heal… Read more